AzTrials
AzTrials

Total Hip Arthroplasty, Postoperative PainNCT07879521

PENG, Suprainguinal Fascia Iliaca Block, and Control After Total Hip Arthroplasty

A study testing Pericapsular nerve group (PENG) block and Suprainguinal Fascia Iliaca Plane Block in people with Total Hip Arthroplasty, Postoperative Pain, run by Uludag University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Total hip arthroplasty can cause significant pain after surgery. Regional anesthesia techniques, such as the pericapsular nerve group (PENG) block and the suprainguinal fascia iliaca plane block, may help reduce postoperative pain and opioid requirements. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Pericapsular nerve group (PENG) block and Suprainguinal Fascia Iliaca Plane Block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
99 participants
Where
1 siteTurkey (Türkiye)
Study dates
2 Apr 2026to 29 Sep 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients who provided written informed consent
  • Patients aged 18 years or older
  • Patients with an American Society of Anesthesiologists (ASA) physical status of I, II, or III
  • Patients scheduled to undergo elective total hip arthroplasty

Who cannot join

  • Patients who did not consent to participate in the study
  • Patients with ASA physical status IV or V
  • Patients using anticoagulant medication or with suspected coagulopathy
  • Patients with an allergy to local anesthetic agents
  • Patients with infection at the intended block site
  • Pregnant patients or patients with suspected pregnancy
Show all 10Show fewer
  • Patients with severe neurological or psychiatric disorders
  • Patients with severe cardiovascular disease
  • Patients with chronic opioid use
  • Patients with hepatic insufficiency or renal failure (glomerular filtration rate <15 mL/min/1.73 m²)

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Bursa Uludağ University Faculty of Medicine Hospital

    Bursa, Bursa

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of the Effects of PENG and Fascia Iliaca Plane Blocks on Postoperative Analgesia and Muscle Strength in Total Hip Arthroplasty: A Randomized, Controlled, Prospective Study

Total hip arthroplasty can cause significant pain after surgery. Regional anesthesia techniques, such as the pericapsular nerve group (PENG) block and the suprainguinal fascia iliaca plane block, may help reduce postoperative pain and opioid requirements. However, these techniques may also affect muscle strength and early mobilization.

This randomized, controlled, prospective study compares the effects of PENG block, suprainguinal fascia iliaca plane block, and no regional block in patients undergoing total hip arthroplasty. Postoperative pain, opioid consumption, quadriceps muscle strength, and hip flexion are evaluated to compare the analgesic effectiveness and motor effects of these approaches.

Being tested
Pericapsular nerve group (PENG) block, Suprainguinal Fascia Iliaca Plane Block
Keywords
Total Hip Arthroplasty, PENG Block, Suprainguinal Fascia Iliaca Block, Postoperative Analgesia, Quadriceps Muscle Strength
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pericapsular nerve group (PENG) blockProcedure or surgery

    Ultrasound-guided pericapsular nerve group (PENG) block performed for postoperative analgesia in patients undergoing total hip arthroplasty.

  • Suprainguinal Fascia Iliaca Plane BlockProcedure or surgery

    Ultrasound-guided suprainguinal fascia iliaca plane block performed for postoperative analgesia in patients undergoing total hip arthroplasty.

Study groups in NCT07879521
Study groupRoleWhat they receive
PENG Block GroupExperimentalParticipants undergoing total hip arthroplasty received a pericapsular nerve group (PENG) block for postoperative analgesia.
Receives: Procedure: Pericapsular nerve group (PENG) block
Suprainguinal Fascia Iliaca Block GroupExperimentalParticipants undergoing total hip arthroplasty received a suprainguinal fascia iliaca plane block for postoperative analgesia.
Receives: Procedure: Suprainguinal Fascia Iliaca Plane Block
Control GroupNo interventionParticipants undergoing total hip arthroplasty did not receive a regional nerve block. Standard perioperative care and analgesia were provided according to the study protocol.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative Pain Scores

    Postoperative pain intensity was assessed using the visual analog scale (VAS), with scores recorded on a 0-100 mm scale. Pain scores were compared among the PENG block, suprainguinal fascia iliaca plane block, and control groups.

    Measured: Up to 24 hours after surgery.

Secondary outcomes (2)
  1. Quadriceps Muscle Strength

    Quadriceps muscle strength was assessed using manual muscle testing (MMT).

    Measured: Up to 24 hours after surgery.

  2. Hip Flexion Angle

    Hip flexion angle was measured in degrees.

    Measured: Up to 24 hours after surgery.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Oct 2026
  2. Study start2 Apr 2026
  3. Primary completion29 Sep 2026
  4. Study completion29 Sep 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
99 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07879521
Sponsor's protocol ID
2026-3/9
Status last verified
Oct 2026
First submitted
10 Oct 2026
Last updated
19 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Pericapsular nerve group (PENG) block and Suprainguinal Fascia Iliaca Plane Block in people with Total Hip Arthroplasty, Postoperative Pain, run by Uludag University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative Pain Scores (time frame: Up to 24 hours after surgery.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in